Sort by
Refine Your Search
-
to achieving these goals. In particular, the development of novel neural network architectures capable of synthesizing data from both sequencing (genomics, transcriptomics) and mass spectrometry (metabolomics
-
facilities include a commercial laser powder bed fusion machine, a commercial laser directed energy deposition machine, and several unique open-architecture laser powder bed fusion metrology testbeds with
-
Characterization and Testing (FACT). The new facility is furnished with several instruments for characterizing pore architecture and evaluating fundamental sorption properties of materials upon exposure to single
-
opportunities are available in developing integrated nanophotonic architectures and devices for realizing compact, efficient, accurate and dynamic quantum AMO systems-on-a-chip. By creating a set of scalable
-
conformation and dynamics in the one-phase region of oppositely charged polyelectrolyte solutions. Systems under investigation include polyelectrolytes of novel chain architecture (multi-arm star and block
-
, cell-fate determination, chromatin architecture organization, and regulation of gene expression. Aberrant DNA methylation has been observed in cancer and neurological disorders. However, investigation of
-
microballistic-based measurement to understand the rate-dependent mechanical behavior of polymers from low impact speeds to ballistic speeds. We are particularly interested in the role of polymer architecture
-
polymer networks, with well-defined chemistry and architecture, are needed to carry out quantitative measurements to establish design principles for programmable disentanglement or dissociation of network
-
), in the CODATA evaluation of fundamental constants, and in more stringent tests of quantum electrodynamics (QED). Experimental efforts include the development of novel ion trap architectures
-
NIST only participates in the February and August reviews. This program explores the development and evaluation of integrated measurement strategies for biopharmaceutical manufacturing using